NCT04649710View on ClinicalTrials.gov

A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 21, 2021

Primary Completion Date

September 21, 2021

Study Completion Date

September 22, 2021

Conditions
Healthy Participants
Interventions
BIOLOGICAL

BMS-986036

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (2)

130021

Local Institution, Changchun

614-735

Local Institution, Busan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04649710 - A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants | Biotech Hunter | Biotech Hunter